SCH-58500
AXP000152.1 · Viral vector gene therapy
- Platform
- adenovirus (Ad5, non-replicating, TP53)
- Targets
- TP53
- Originator
- Canji (Schering-Plough)
- Sponsor
- Schering-Plough
Names
Virus
- Role
- In vivo gene transfer
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5
- Replication
- non replicating
- Modifications
- non-replicating adenoviral vector encoding wild-type human p53
- Transgenes
- TP53
- Route
- intraperitoneal, intratumoral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C2423
Approvals
No regulatory approval recorded.
Clinical trials (3)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT00004080 | Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors | Completed | Phase 1 | 1999-12 | Brain and Central Nervous System Tumors | ||
| NCT00002960 | SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) | Completed | Phase 1 | 1999-06 | 2000-07 | 59 | Fallopian Tube Cancer; Metastatic Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
| NCT00003880 | Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer | Terminated | Phase 2/3 | 1999-02 | 2001-08 | 132 | Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Unconfirmed matches (5)
Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions | Matched by |
|---|---|---|---|---|---|---|---|---|
| NCT02429037 | P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer | Unknown | Phase 2 | 2015-05 | 2018-12 | 60 | Advanced Head and Neck Cancer | intervention named: rAd/p53 |
| NCT02418988 | Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma | Unknown | Phase 2 | 2014-07 | 2017-05 | 120 | Advanced Adult Hepatocellular Carcinoma | name in intervention: rAd/p53 |
| NCT01574729 | Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma | Unknown | Phase 2 | 2012-08 | 2015-08 | 120 | Non-small Cell Lung Cancer | name in intervention: rAd/p53 |
| NCT00902083 | rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors | Unknown | Phase 4 | 2009-06 | 2012-07 | 600 | Advanced Oral and Maxillofacial Malignant Tumors | name in title: rAd/p53 |
| NCT00902122 | rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors | Unknown | Phase 4 | 2009-05 | 2012-08 | 600 | Advanced Malignant Thyroid Tumors | name in intervention: rAd/p53 |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 16082381 | Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. | Cancer gene therapy | 2006 | name in title: SCH-58500 |
| PMID 12637944 | Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer. | Cancer gene therapy | 2003 | name in abstract: SCH-58500 |
| PMID 11844817 | Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2002 | name in abstract: SCH-58500 |
| PMID 12082455 | A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. | Cancer gene therapy | 2002 | cited by trial NCT00002960 |
| PMID 12082456 | Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500. | Cancer gene therapy | 2002 | cited by trial NCT00002960 |
| PMID 11251006 | Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2001 | name in abstract: SCH-58500 |
| PMID 11249761 | Technology evaluation: Sch-58500, Canji. | Current opinion in molecular therapeutics | 2000 | name in title: SCH-58500 |
Unconfirmed matches (3)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 32851960 | Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer. | Current gene therapy | 2020 | name in title: rAd/p53 |
| PMID 26146864 | A patient with a large intrathoracic malignant schwannoma who showed a complete clinical response to rAd-p53-combined with radiotherapy. | Anti-cancer drugs | 2015 | name in title: rAd/p53 |
| PMID 24479409 | Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial. | BMC medicine | 2014 | name in title: rAd/p53 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 25364261 | Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives. | OncoTargets and therapy | 2014 | name in abstract: SCH-58500 |
| PMID 24107178 | Advances in adenovirus-mediated p53 cancer gene therapy. | Expert opinion on biological therapy | 2013 | name in abstract: SCH-58500 |
| PMID 14571286 | Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology | 2003 | name in abstract: SCH-58500 |
| PMID 11812930 | Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene. | Toxicological sciences : an official journal of the Society of Toxicology | 2002 | name in title: SCH-58500 |
| PMID 11812931 | Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene. | Toxicological sciences : an official journal of the Society of Toxicology | 2002 | name in title: SCH-58500 |
| PMID 12487057 | Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond. | Surgical oncology clinics of North America | 2002 | name in abstract: SCH-58500 |
| PMID 12522437 | Intravascular adenoviral agents in cancer patients: lessons from clinical trials. | Cancer gene therapy | 2002 | name in abstract: SCH-58500 |
| PMID 10601610 | NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft model. | Oncology reports | 2000 | name in abstract: SCH-58500 |
| PMID 11032912 | Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide in preclinical cancer models. | Oncology reports | 2000 | name in title: SCH-58500 |
| PMID 11129289 | Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. | Cancer gene therapy | 2000 | name in abstract: SCH-58500 |
| PMID 10412949 | Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer. | Cancer chemotherapy and pharmacology | 1999 | name in abstract: SCH-58500 |
| PMID 10595917 | The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies. | The American journal of pathology | 1999 | name in abstract: SCH-58500 |
Unconfirmed matches (15)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 38523676 | Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. | Genes & diseases | 2024 | name in title: rAd/p53 |
| PMID 32013587 | Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-p53 Combined with Chemotherapy Treatment. | Human gene therapy | 2020 | name in title: rAd/p53 |
| PMID 33060772 | Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models. | Scientific reports | 2020 | name in title: rAd/p53 |
| PMID 29281902 | Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy. | Human gene therapy | 2018 | name in title: rAd/p53 |
| PMID 29328445 | The effects of interleukin 2 and rAd-p53 as a treatment for glioblastoma. | Molecular medicine reports | 2018 | name in title: rAd/p53 |
| PMID 30405797 | Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer. | Oncology letters | 2018 | name in title: rAd/p53 |
| PMID 28621316 | Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro. | Cancer gene therapy | 2017 | name in title: rAd/p53 |
| PMID 27446369 | Recurrent myoepithelial carcinoma of the submandibular gland treated by rAd-p53 combined with radiotherapy: A case report. | Oncology letters | 2016 | name in title: rAd/p53 |
| PMID 25496374 | Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors. | Expert opinion on biological therapy | 2015 | name in title: rAd/p53 |
| PMID 22441128 | Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo. | Gene | 2012 | name in title: rAd/p53 |
| PMID 22090785 | rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy. | World journal of gastroenterology | 2011 | name in title: rAd/p53 |
| PMID 20678439 | [Experimental studies of rAd-p53 injection by interventional approach for the treatment of rabbit VX2 liver cancer]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology | 2010 | name in title: rAd/p53 |
| PMID 17129471 | [The combination of recombinant rAd-p53 and adriamycin for management of primary drug resistance in chemotherapy of lung squamous cell cancer]. | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases | 2006 | name in title: rAd/p53 |
| PMID 8622881 | Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. | Oncogene | 1996 | name in abstract: ACN53 |
| PMID 8573613 | Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. | Human gene therapy | 1995 | name in abstract: ACN53 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| M01RR000079 | C98-118-01: SCH58500 & chemotherapy in colorectal cancer metastatic to liver | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | VENOOK, ALAN PAUL | 1997–2003 | name in title: SCH-58500 |
| M01RR000039 | GENE THERAPY OF PRIMARY & METASTATIC MALIGNANT LIVER TUMORS USING SCH58500 | EMORY UNIVERSITY | STALEY, CHARLES A | 1999–2002 | name in title: SCH-58500 |
| M01RR000040 | UPCC: TRIAL OF INTRAVENOUS PV701 IN PTS W SOLID TUMORS | UNIVERSITY OF PENNSYLVANIA | STERMAN, DANIEL | 1999–2002 | name in abstract: SCH-58500 |
| M01RR000865 | ADMINISTERING SCH 58500 TO TREAT ADENOCARCINOMA OF PROSTATE | UNIVERSITY OF CALIFORNIA LOS ANGELES | BELLDEGRUN, ARIE S | 1999–2001 | name in title: SCH-58500 |
Notes
Recombinant adenovirus-p53 from Canji/Schering-Plough, studied intraperitoneally in ovarian cancer and intratumorally in NSCLC in the late 1990s and early 2000s; no benefit shown and development stopped. A separate construct from Gendicine (AXP000141) and contusugene ladenovec (AXP000142). Also called ACN53.
How to cite
SCH-58500 (AXP000152.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000152.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.